Search for: "Mays v. Monsanto Company et al" Results 1 - 20 of 27
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 May 2007, 8:52 pm
Monsanto Company et. al. v. [read post]
15 Jun 2013, 6:33 am
According to the interpretation of Article 9 of the Biotechnology Directive adopted by the CJEU in the Monsanto case (Monsanto Tchnology v. [read post]
10 Oct 2010, 6:21 am
Also brought within the IPO’s corral is the decision in Dr Reddy’s Laboratories (UK) Ltd v Eli Lilly & Co Ltd [2010] RPC 8 (noted by the IPKat here), in which the Court of Appeal delved into the murky depths of selection invention – asking, in the process, where a wise man would hide a leaf… The sections on supplementary protection certificates has also been updated in light of the decisions of the High Court in Yeda Research and Development Company Ltd… [read post]
17 Jan 2010, 10:37 am
Opinion below (4th Circuit) Petition for certiorari Brief in opposition Petitioner’s reply Docket: 09-475 Title: Monsanto Company v. [read post]
23 Mar 2015, 9:03 am by WIMS
Reply of petitioners Michigan, et al. filed and more. [read post]
23 May 2011, 2:20 am by Kelly
Advising inventors, their spouses, and their start-up companies: James Joyce v Armstrong Teasdale (Patently-O) District Court N D California: Use of patent reexamination evidence in parallel litigation: Volterra Semiconductor Corporation v Primarion Inc (Patents Post-Grant) District Court E D California: Government’s approval of false marking settlement precludes later challenge that settlement was “staged” and therefore lacks preclusive effect: Champion… [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files opposition: Teva… [read post]
1 Oct 2010, 5:47 am by Jon L. Gelman
Stricker, et al., CV 09-BE-2423-E (USDCT ND Alabama) Filed September 30, 2010 3:59pm. [read post]
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay generics in 2007:… [read post]
8 Feb 2008, 7:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Record labels sue Baidu over providing links to file-sharing sites: (Ars Technica), (Techdirt), (Out-Law), (IP Law360), (Copyfight), Merck’s Fosamax patent expires: Watson Pharmaceuticals to distribute authorized generic version, Teva and Barr also launch FDA approved generic versions: (SmartBrief), (Patent Circle), (In … [read post]
10 Sep 2017, 3:07 pm by Wolfgang Demino
FORRESTER WINNE, et al., Plaintiffs,v.NATIONAL COLLEGIATE STUDENT LOAN TRUST 2005-1, et al., Defendants.No. 1:16-cv-00229-JDL.United States District Court, D. [read post]